Loading organizations...
Maev develops human-grade raw dog food and supplements, utilizing whole, natural ingredients. Their products are formulated by PhD veterinary nutritionists, providing a balanced diet free from processed components, meals, or artificial preservatives. This approach integrates canine biology and the microbiome to enhance dog wellness.
Founded in 2018 by MIT engineer Katie Spies, Maev's genesis came from Spies's personal journey with her dog, George. His health issues exposed the compromises in traditional dog food, compelling her to create a transparent and genuinely healthy nutritional alternative for pets.
The company serves dog owners committed to superior pet nutrition. Maev's vision is to significantly improve canine lives by offering food that is both appealing and contributes to their well-being. It seeks to establish a new standard in pet nutrition, emphasizing long-term health and vitality.
Maev has raised $19.0M across 2 funding rounds.
Maev has raised $19.0M in total across 2 funding rounds.
Maev is a pet nutrition company specializing in human-grade raw dog food, supplements, treats, and toppers formulated by PhD veterinary nutritionists to support canine health issues like digestion, mobility, anxiety, skin, and coat.[1][2][4] It serves dog owners seeking premium, unprocessed alternatives to conventional kibble, solving problems of low-quality ingredients, fillers, and preservatives in standard pet foods by offering AAFCO-compliant, science-backed products made with USDA proteins.[1][2][4] Founded in 2018 (with some sources noting 2019), Maev has raised $19M total, including a Series A-II round of $10M about three years ago, and reports 87% of surveyed customers seeing health improvements.[1][4]
Maev was founded by Katie Spies, an MIT-trained engineer and dog parent, inspired by her dog George's health scare, which prompted her to scrutinize commercial dog food and create a better option using human-grade ingredients.[1][2] Unable to find trustworthy products free of processed compromises, Spies developed Maev's raw food lineup with input from veterinary experts, launching in 2018 from New York City headquarters at 379 W Broadway.[1][2] Early traction came from George's transformation and word-of-mouth among dog owners, evolving into a direct-to-consumer brand with targeted formulas and a growing subscriber base.[1][2][4]
Maev rides the pet tech and direct-to-consumer wellness wave, leveraging e-commerce, subscription models, and data-driven nutrition amid rising demand for premium pet care—U.S. pet industry spending hit record highs pre-2025, fueled by humanization of pets post-pandemic.[1][4] Timing aligns with advances in veterinary science and supply chain tech for fresh raw delivery, countering market forces like inflation-hit mass-market kibble with high-margin, personalized alternatives.[2] It influences the ecosystem by normalizing raw feeding, partnering with influencers like Rumer Willis, and challenging incumbents through transparency and vet credentials, potentially expanding to tech integrations like health-tracking apps.[1][4]
Maev is poised for scaling via new proteins, international expansion, and potential tech add-ons like AI-personalized feeding plans, capitalizing on pet humanization and raw diet trends amid Series A momentum.[1][4] Evolving regulations on pet food standards and supply chain resilience will shape it, with influence growing through community loyalty and vet endorsements—watch for Series B to fuel DTC dominance. This raw revolution started with one dog's bowl, now filling thousands with science-backed nutrition.
Maev has raised $19.0M in total across 2 funding rounds.
Maev's investors include 11, Baukunst, Bolt, Contrary Capital, Springdale Ventures, VMG Partners, Wave Capital, Ron Pragides, Sean Harper.
Maev has raised $19.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 1, 2022 | $10M Series A | — | 11, Baukunst, Bolt, Contrary Capital, Springdale Ventures, VMG Partners, Wave Capital, RON Pragides, Sean Harper | Announced |
| Dec 1, 2021 | $9M Seed | — | 11, Baukunst, Contrary Capital, Springdale Ventures, VMG Partners, RON Pragides, Sean Harper | Announced |
